InflaRx NV (IFRX)
2.17
+0.46
(+26.90%)
USD |
NASDAQ |
Nov 14, 12:18
InflaRx Profit Margin (Quarterly): -217.8K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -217.8K% |
| March 31, 2024 | -26.80K% |
| Date | Value |
|---|---|
| December 31, 2023 | -696.8K% |
| September 30, 2023 | -12.26K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-696.8K%
Minimum
Dec 2023
-12.26K%
Maximum
Sep 2023
-238.4K%
Average
-122.3K%
Median
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -10.03K% |
| BioNTech SE | 15.91% |
| Immatics NV | -96.09% |
| CureVac NV | -502.5% |
| ATAI Life Sciences NV | -20.99K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.91% |
| Return on Assets | -41.76% |
| Return on Invested Capital | -47.28% |
| Gross Profit Margin (Quarterly) | -5.38K% |
| Operating Margin (Quarterly) | -242.2K% |
| Return on Net Operating Assets | -182.0% |